# PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

> **NCT02608242** · PHASE1 · TERMINATED · sponsor: **Yuhan Corporation** · enrollment: 123 (actual)

## Conditions studied

- Hypertension
- Hyperlipidemia

## Interventions

- **DRUG:** YH22189
- **DRUG:** Twynsta 80/10mg
- **DRUG:** Crestor 20mg

## Key facts

- **NCT ID:** NCT02608242
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 123 (ACTUAL)
- **Why stopped:** sponsor decision
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608242, "PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02608242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*